King Faisal Specialist Hospital and Research Centre (KFSH&RC) marked the 40th anniversary of its Cyclotron and Radiopharmaceuticals Department today. Recognised internationally as a centre for education, training, and research, the department, which is accredited by the International Atomic Energy Agency (IAEA), fulfils about 70% of Saudi Arabia’s demand for radioactive pharmaceuticals. The commemorative event took place at the hospital’s headquarters in Riyadh, with H.E. CEO Dr. Majid Al Fayyadh in attendance.
Since its inception in 1983, the department has manufactured over 650,000 doses of 30 different types of diagnostic and therapeutic radioactive pharmaceuticals. This production has supported 50 specialised centres throughout Saudi Arabia, fulfilling 70% of the nation’s demand. Looking ahead, the KFSH&RC aims to increase its supply to cover 90% of the demand, working towards achieving self-sufficiency in radioactive pharmaceuticals within Saudi Arabia.
Dr Majid Al Fayyadh expressed his sincere appreciation to all those who contributed to this remarkable journey. He stated: “As we celebrate this anniversary, we look ahead with optimism, fueled by a shared vision of continued innovation and excellence in healthcare. This milestone reflects the dedication of our team, the vision of our institution, and our firm pursuit of advancing healthcare. Together, we navigate the future with a collective determination to redefine possibilities and elevate medical standards for the well-being of our community.”
Commencing with a captivating short film, the audience delved into the remarkable journey of establishing the Cyclotron and Radiopharmaceuticals Department. The film highlighted the historic moment in 1978 when the inaugural cyclotron, powered by a 26 Mega Electron Volts proton beam (CS-30), was installed at the hospital premises. To complement the film, an interactive exhibition provided attendees with a comprehensive understanding of cyclotron production and the creation of radioactive pharmaceuticals. This immersive experience also sheds light on the diverse applications of these novel technologies in the medical field.
To uphold these ambitions, the department ensures stringent quality standards through an integrated unit for product quality control and management. This involves adherence to Good Manufacturing Practices (GMP), national standards set by the Saudi Food and Drug Authority (SFDA) and the Nuclear and Radiological Regulatory Commission (NRRC), international standards (Quality Management System QMS), and ISO 9001 specifications. Rigorous control measures in operational processes ensure periodic material evaluations for sustained validity, anchoring the department’s reputation for reliable production and exceptional quality maintenance.
King Faisal Specialist Hospital and Research Centre is considered among the most prominent in the world in providing tertiary healthcare, a pioneer in innovation, and an advanced medical research and education centre. It also seeks to develop medical technologies and raise the standards of health care worldwide in partnership with prominent local, regional, and international institutions with the aim of achieving world-class service in the clinical, research, and educational fields.